Cargando…

A phase 3 clinical trial with ISIS-TTRRx, a 2nd-generation antisense oligonucleotide targeting transthyretin (TTR), for the treatment of TTR amyloid cardiomyopathy

Detalles Bibliográficos
Autores principales:	Millns, Helen, Bergemann, Rito, Ackermann, Elizabeth, Monia, Brett, Lukas, Mary Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641994/ http://dx.doi.org/10.1186/1750-1172-10-S1-P8

Ejemplares similares

Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
por: Benson, Merrill D, et al.
Publicado: (2015)

The ISIS-TTRRx-CS2 phase 3 study in patients with familial amyloid polyneuropathy: Baseline results of the first 100 patients for the NIS, NIS+7 and mNIS+7 using different methods of scoring: identification of consistencies and key differences
por: Bergemann, Rito, et al.
Publicado: (2015)

Transthyretin familial amyloid polyneuropathy (TTR‐FAP): Parameters for early diagnosis
por: Escolano‐Lozano, Fabiola, et al.
Publicado: (2017)

Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L(Rx) (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
por: Coelho, Teresa, et al.
Publicado: (2021)

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis
por: Niemietz, Christoph, et al.
Publicado: (2015)

Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD
por: Rios, Xabier, et al.
Publicado: (2019)

Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP
por: Parman, Yesim, et al.
Publicado: (2016)

The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa
por: Jacobson, Daniel R., et al.
Publicado: (2016)

The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis
por: Bemporad, Francesco, et al.
Publicado: (2022)

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease
por: Raya-Cruz, Manuel, et al.
Publicado: (2015)

Teachings from the French database of TTR familial amyloidotic polyneuropathy (TTR-FAP): large genetic and phenotypic heterogeneity, usefulness of TTR gene testing.
por: Adams, David, et al.
Publicado: (2015)

Uptake of Aggregating Transthyretin by Fat Body in a Drosophila Model for TTR-Associated Amyloidosis
por: Pokrzywa, Malgorzata, et al.
Publicado: (2010)

Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy
por: Damy, Thibaud, et al.
Publicado: (2016)

Cellular environment of TTR deposits in an animal model of ATTR—Cardiomyopathy
por: Teixeira, Cristina, et al.
Publicado: (2023)

Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area
por: Mazzeo, Anna, et al.
Publicado: (2015)

Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis
por: Iorio, Andrea, et al.
Publicado: (2017)

Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy “in disguise”
por: Grandis, Marina, et al.
Publicado: (2018)

Structural Stabilization of Human Transthyretin by Centella asiatica (L.) Urban Extract: Implications for TTR Amyloidosis
por: Eze, Fredrick Nwude, et al.
Publicado: (2019)

TTR sequencing should be considered ahead of hypertrophic cardiomyopathy in Afro-Americans
por: Raphalen, Jean Herlé, et al.
Publicado: (2015)

The diagnostic accuracy of Sudoscan in TTR-FAP
por: Castro, Jose, et al.
Publicado: (2015)

Therapeutic education programme in TTR-FAP
por: Théaudin, Marie, et al.
Publicado: (2015)

Transthyretin-related Familial Amyloid Polyneuropathy (TTR-FAP) caused by a very rare, de novo mutation in a Polish patient.
por: Lipowska, Marta, et al.
Publicado: (2015)

Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan
por: Miyake, Zenshi, et al.
Publicado: (2018)

Diflunisal compassive use in transthyretin familial amyloidotic polyneuropathy (TTR-FAP): report of the first Spanish experience
por: Contesse, Sebastián E Azorín, et al.
Publicado: (2015)

In silico analysis decodes transthyretin (TTR) binding and thyroid disrupting effects of per- and polyfluoroalkyl substances (PFAS)
por: Dharpure, Rupal, et al.
Publicado: (2022)

Studies on the Requirement of Transthyretin Protein (BxTTR-52) for the Suppression of Host Innate Immunity in Bursaphelenchus xylophilus
por: Wen, Tong-Yue, et al.
Publicado: (2022)

Identification of a new variant of TTR involved in familial amyloid cardiomyopathy (FAC) in Brazil: from the patient to the protein
por: Ferreira, Priscila, et al.
Publicado: (2015)

Retinal and choroidal vascular abnormalities in TTR-FAP
por: Rousseau, Antoine, et al.
Publicado: (2015)

Preimplantation genetic diagnosis for TTR-FAP in Portugal
por: Carvalho, Filipa
Publicado: (2015)

Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis
por: Kapoor, Mahima, et al.
Publicado: (2019)

TTR: Time in Therapeutic Range or “The Troublesome Report”?
por: Reiffel, James A.
Publicado: (2019)

Lessons from the first-in-human in vivo CRISPR/Cas9 editing of the TTR gene by NTLA-2001 trial in patients with transthyretin amyloidosis with cardiomyopathy
por: Kotit, Susy
Publicado: (2023)

Population Pharmacokinetic–Pharmacodynamic Modeling of Inotersen, an Antisense Oligonucleotide for Treatment of Patients with Hereditary Transthyretin Amyloidosis
por: Yu, Rosie Z., et al.
Publicado: (2020)

Hypertrophic cardiomyopathy caused by a heterozygous variant in TTR gene: A case report
por: Yuan, Huayuan, et al.
Publicado: (2023)

Non-invasive risk stratification of patients with TTR amyloidosis
por: Scherer, Katrin A, et al.
Publicado: (2013)

Neurophysiological pitfalls in TTR-FAP Val30Met
por: Conceição, Isabel, et al.
Publicado: (2015)

Management of stage 1 TTR FAP: French experience
por: Adams, David, et al.
Publicado: (2015)

Neurophysiological pitfalls in TTR-FAP Val30Met
por: Conceição, Isabel, et al.
Publicado: (2015)

The phenotypical expression of an European inherited TTR amyloidosis in Brazil
por: Cruz, Márcia Waddington, et al.
Publicado: (2015)

TTR amyloidosis: a scientific journey since Andrade
por: Saraiva, Maria João
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2k86pul02i47g6aac8cnqnoije